Filing Details
- Accession Number:
- 0001127602-25-018401
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-01 18:02:45
- Reporting Period:
- 2025-06-30
- Filing Date:
- 2025-07-01
- Accepted Time:
- 2025-07-01 18:02:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882095 | Gilead Sciences Inc. | GILD | Biological Products, (No Disgnostic Substances) (2836) | 943047598 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1638643 | Patrick Daniel O'day | 333 Lakeside Drive Foster City CA 94404 | Chairman & Ceo | Yes | Yes | No | No |
Transaction Summary
| Sold: | 10,000 shares | Avg. Price: $110.45 | Total Value: $1,104,483.74 |
| Number of Shares After Transactions: | 615,725 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-30 | 9,400 | $110.40 | 616,325 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-30 | 600 | $111.15 | 615,725 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025.
- Sale prices reported for the transactions reported here range from $110.03 to $111.00. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
- Sale prices reported for the transactions reported here range from $111.03 to $111.17. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
Billionaire Hedge Funds
